About · Contact us · Terms of use · Dr. T
References
1. Mahan LK, Arlin MT: Krouse's Food, Nutrition, and Diet Therapy, 8th ed., pp. 100-101, 1992, Philadelphia: W.B. Saunders Co.
2. Chojkier M, et al: "Specifically decreased collagen biosynthesis in scurvy dissociated from and effect on proline hydroxylation and correlate with body weight loss in vitro studies in guinea pig calvarial bones," J. Clin. Invest., 1984; 72:826-35.
3. Stassen FLH, et al.: "Activation of prolyl hydroxylase in L-929 fibroblasts by ascorbic acid," Proc. Natl. Acad. Sci. USA, 1973; 70:1090-3.
4. Myllyla R, et al: "The role of ascorbate in the prolyl hydroxylase reaction," Biochem. Biophys. ��es. Commun., 1978; 83:441-8.
5. Mussini E, et al.: "Collagen proline hydroxylase in wound healing, granuloma formation, scurvy, and growth," Science, 1967; 157:927-9. Anderson R: "The immuno-stimulatory, anti-inflammatory, and antic properties of ascorbate," Adv. Nutr. ��es., 1984; 6:19-45.
6. Bendich A, et al: "The antioxidant role of vitamin C," Adv. Free ��ad. Biol. Med., 1986; 2:419-44.
7. Anderson R: "Ascorbic acid and immune functions." In Counsel J.N., Hornig DH, eds, Vitamin C: Ascorbic Acid, London: Applied Science Publishers, 1981:249-72.
8. Peters EM, et al.: "Vitamin C supplementation reduces the incidence of post-race symptoms of upper-respiratory-tract infection in
9. ultramarathon runners," Am. J. Clin. Nutr., 1993; 57:170-4.
10. Vojdani A., Ghoneum M.: "In vivo effect of ascorbic acid on enhancement of human natural killer cell activity," Nutr. ��es., 1993; 13:753-64. Ganguly R, et al.: "Macrophage function of vitamin C-deficient guinea pigs," Am. J. Clin. Nutr., 1976; 29:762-65.
11. Anderson TW, et al.: "Vitamin C and the Common Cold: A double-blind trial," Can. Med. Ass. J., 1972; 105:503-508.
12. Chatterjee A, et al.: "Effects of L-lysine administration of certain aspects of ascorbic acid metabolism," Int'l J. Vit. Nutr. ��es., 1976;
13. 46:286-90.
14. Martindale: The Extra Pharmacopeia, 1982, JEF Reynolds, ed., London: The Pharmaceutical Press.
15. Sowden JC: "Occurrence, properties, and synthesis of the monosaccharides." In The Carbohydrates Chemistry, Biochemistry, Physiology, p. 84, 1957. W. Pigman, ed., New York: Academic Press.
16. Lang K: Biochemie der Ernahrung, 1979, Dr. D. Steinkopff Verlag, Darmstadt, p. 27.
17. Karrer P: Organic Chemistry, 4th English ed. p. 313, 1950. Elserner Publishing Co., Inc.
18. Banerjee SK, et al.: "Effect of sulphur-containing amino acids and anabolic steroid on the metabolism of ascorbic acid in rats fed on necrogenic diets," Ind. J. of Biochem. Biophys., 1973; 10:27-30.
19. Lewin S.: "Vitamin C: Its Molecular Biology and Medical Potential," 1976, London: Academic Press.
20. Dixon SJ, Wilson JX: "Transforming growth factor-beta stimulates ascorbate transport activity in osteoblastic cells," Endocrinology, 130 (1) p. 484-9.
21. Johnston CS, et al.: "Vitamin C elevates red blood cell glutathione in healthy adults," Am. J. Clin. Nutr., 1993; 58:103-5.
22. Miller JZ, et al.: "Therapeutic effect of vitamin C. A co-twin control study," JAMA, 1977; 237-238.
23. Cahil RJ, et al.: "Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps," Gut.:963-967.
24. Alternative Medicine: The Definitive Guide, Compiled by The Burton Goldberg Group, James Strohecker, Executive Editor, Future Medicine Publishing, Inc., Puyallup, Washington, 1994.
25. Life Extension Report, Vol. 13, No. 5, April, 1993.
26. Jagetia GC, Ganapathi NG, Dept. of Radiobiology, Kasturba Medical College. Manipal. Karnataka. Mutation ��es. (1989): 224, 507.
27. Tripathi SN, Misra AK, Upadhyaya KN, Dixit OP, Srivastava SK: Research Fellow, Dept. of Kayachikitsa, Institute of Medical Sciences, Banaras Hindu University, Varanasi, U.P., J. ��es. Ind. Med., Yoga & Homeo, (1977): 1, 49.
28. Kishore B, Hazra DU, Sachan AS, Agrawal BM, Bharadwaj AK, and Mehrotra MMN, Probe (1978): 2, 125.
29. Prasad KN, et al: "High doses of multiple antioxidant vitamins: Essential ingredients in improving efficacy of standard cancer therapy," J. Amer. College of Nutrition, Vol 18, No. 1, 13-25 (1999).
30. Preventative Effect of Active Hexose Correlated Compound (AHCC) on the Recurrence of PostoperativeHepatocellular Carcinoma Patients. XXXIIIrd Congress of the European Society for Surgical Research. 1998 p74.
31. Immunomodulatory and AntiCancer Effects of Active HemiCellulose Compound (AHCC), International Journal of Immunotherapy XI (1) 23-28 (1995) Ghoneum M., Wimbley M., Salem F., McKlain A., Attallah N., Gill G.
32. NK-Immunomodulation by Active Hemicellulose Compound in 17 Cancer Patients, Society of Natural Immunity, Taormina, Italy May 25-28, 1994 p56 Mamdooh Ghoneum, PhD.
33. Enhancement of Human NK Cell Activity In-Vivo by Active Hemicellulose Compound (AHCC), Abstract of 7th Annual Conference on Clinical Immunology, November 13-15, 1992 Ghoneum M., et al.
34. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma, Anti-Cancer Drugs 1998. v9, pp343-350. Kazuhiro Matsushita, Yasuhiro Kuramitzu, Youichi Ohiro, Manuba Obara, Masanobu Kobayashi, Yong-Qing Li and Masuo Hosokawa.
35. Protective Effects of AHCC on Carbon Tetrachloride Induced Liver Injury in Mice, Natural Medicine, 51, 310-315, 1997.Sun B., Wakame K., Mukota T., Toyoshima A., Kanazawa T., Kosuna K.
36. Active Hexose Correlated Compound (AHCC) Protects Against Cytosine Arabinoside Induced Alopecia in the Newborn Rat Model, Japanese Journal of Cancer Research 89, p2405. Mukoda T., Sun B., Kosuna K.
37. The Development and Application of Active Hemicellulose Compound (AHCC) Bio Industry September 1993 Volume 10. Ken-ichi Kosuna.
38. Di Luzio NR, Williams DL, McNamee RB, Edwards BF, Kitahama A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer. 1979;24:773-779.
39. Imura H, Ohno N, Suzuki I, Yadomae T. Purification, antitumor activity, and structural characterization of ß-1,3-glucans from Peziza vesiculosa. Chem Pharm Bull. 1985;33:5096-5099.
40. Yadomae T. Structure and biological activities of fungal ß-1,3 glucans. Yakugaku Zasshi. 2000;120:413-431.
41. Ogasawara M, Murata J, Kamitani Y, Hayashi K, Saiki I. Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver. Clin Exp Metastasis. 1999;17:283-291.
42. Ross GD, Vetvicka V, Yan J, Xia Y, Vetvicková J. Therapeutic intervention with complement and ß-glucan in cancer. Immunopharmacol. 1999;42:61-74.
43. Nakano T, Oka K, Hanba K, Morita S. Intratumoral administration of sizofilan activates Langerhan cell and T-cell infiltration in cervical cancer. Clin Immunol Immunopathol. 1996;79:79-86.
44. Suzuki I, Hashimoto K, Ohno N, Tanaka H, Yadomae T. Immunomodulation by orally administered ß glucan in mice. Int J Immunopharmac. 1989;11:761-769.
45. Ikuzawa M, Matsunaga K, Nishiyama S, Nakajima S, Kobayashi Y, Andoh T, Kobayashi A, Ohhara M, Ohmura Y, Wada T, Toshikumi C. Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin). Int J Immunopharmacol. 1988;10:415-423.
46. Torisu M, Hayashim Y, Ishmitsu T, Fujimura T, Iwasaki K, Katano M, Yamamoto H, Kimura Y, Takesue M, Kondo M, Nomoto K. Significant propagation of disease-free period gained by oral polysaccharide (PSK) administration after curative surgical operation of colorectal cancer. Canc Immunol Immunother. 1990; 31:261-268.
47. Xu, G. The effects of PSP on improving immunity for gastric cancer patients In: Yang, Q, Kwok C, eds. PSP International Symposium. Hong Kong: Fudan University Press; 1993:263-264 Abstract.
48. Namba H. Results of non-controlled clinical study for various cancer patients using maitake D- fraction. Explore. 1995;6:19-21.
49. Suzuki I, Sakuri T, Hashimoto K, Oikawa S, Masuda A, Ohsawa M, Yadomae T. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered ß-glucan in mice.Chem Pharm Bull 1991;39:1606-1608.
50. Kasai S, Fujimoto S, Nitta K, Baba H, Kunimoto T. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan. J Pharmacobiodyn. 1991;14(9):519-25.
51. MItomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, NIshiyama K, Amano T, Takahashi T, Murayama N, Oka H, Oya K, Noto T, Ogawa N. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Dis Colon Rectum. 1992;35:123-130.
52. Hayakawa K, Mitsuhashi N, Saito Y< Takahashi M, Kanato S, Shiojima K, Furuta M, Niibe H. Effect of krestin (PSK) as adjuvant treatment of the prognosis after radical radiotherapy in patients with non-small cell lung cancer. Anticancer Res 1993;13:1815-1820.
53. Reduction of the Side Effects of Anticancer Drugs by Active Hexose Correlated Compound, 90th Proceedings of the American Association for Cancer Research B. Sun et al. (Amino Up Chemical Co., Ltd) 1999
54. Protective effects of AHCC on Carbon Tetrahydrochloride Induced Liver Injury in Mice, Natural Medicines 51(4),310-315 (1997) B. Sun et al. (Amino Up Chemical Co., Ltd.) 1998.
55. Active Hexose Correlated Compound (AHCC) Protects Against Cytosine Arabinoside Induced Alopecia in the Newborn Rat Animal Model, 57th Annual Meeting of the Japanese Cancer Association, T. Mukoda et al. (Amino Up Chemical Co., Ltd.) 1998.
56. Combination Therapy of Active Hexose Correlated Compound (AHCC) Plus UFT Significantly Reduces the Metastasis of Rat Mammary Carcinoma, Anti-Cancer Drugs 1998, 9, 343-350. K. Matsushita et al. (University School of Medicine, Laboratory of Pathology, Cancer Institute, Hokkaido) 1998.
57. Prophylactic Efficiency of a Basidio-mycetes Preparation AHCC against Lethal Opportunistic Infection in Mice, Yakugaku Zassi 2000,
58. 120, 749-753H. Ishibashi et al. (Department of Microbiology and Immmunology, Teikyo University of Medicine).
- Improving Effect of Active Hexose Correlated Compound (AHCC) on the Prognosis of Postoperative Hepatocellular Carcinoma Patients, 34th Congress of the European Society for Surgical Research (Bern, Switzerland) Y. Kamiyami et al. (First Department of Surgery, Kansai Medical University) 1999.





